Karamitopoulou E - Search Results

1

Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.

Karamitopoulou E, Wenning AS, Acharjee A, Zlobec I, Aeschbacher P, Perren A, Gloor B. Karamitopoulou E, et al. Gut. 2023 Aug;72(8):1523-1533. doi: 10.1136/gutjnl-2022-329371. Epub 2023 Feb 15. Gut. 2023. PMID: 36792355

2

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).

Karamitopoulou E, Zlobec I, Gloor B, Kondi-Pafiti A, Lugli A, Perren A. Karamitopoulou E, et al. J Transl Med. 2013 Dec 14;11:311. doi: 10.1186/1479-5876-11-311. J Transl Med. 2013. PMID: 24330423 Free PMC article.

3

Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma.

Wartenberg M, Zlobec I, Perren A, Koelzer VH, Gloor B, Lugli A, Karamitopoulou E. Wartenberg M, et al. Among authors: karamitopoulou e. Oncotarget. 2015 Feb 28;6(6):4190-201. doi: 10.18632/oncotarget.2775. Oncotarget. 2015. PMID: 25669968 Free PMC article.

4

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.

Galván JA, Zlobec I, Wartenberg M, Lugli A, Gloor B, Perren A, Karamitopoulou E. Galván JA, et al. Among authors: karamitopoulou e. Br J Cancer. 2015 Jun 9;112(12):1944-50. doi: 10.1038/bjc.2015.177. Epub 2015 May 19. Br J Cancer. 2015. PMID: 25989272 Free PMC article.

5

PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential.

Wartenberg M, Centeno I, Haemmig S, Vassella E, Zlobec I, Galván JA, Neuenschwander M, Schlup C, Gloor B, Lugli A, Perren A, Karamitopoulou E. Wartenberg M, et al. Among authors: karamitopoulou e. Eur J Cancer. 2016 Sep;65:80-90. doi: 10.1016/j.ejca.2016.06.013. Epub 2016 Jul 29. Eur J Cancer. 2016. PMID: 27475963

6

Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.

Wartenberg M, Cibin S, Zlobec I, Vassella E, Eppenberger-Castori S, Terracciano L, Eichmann MD, Worni M, Gloor B, Perren A, Karamitopoulou E. Wartenberg M, et al. Among authors: karamitopoulou e. Clin Cancer Res. 2018 Sep 15;24(18):4444-4454. doi: 10.1158/1078-0432.CCR-17-3401. Epub 2018 Apr 16. Clin Cancer Res. 2018. PMID: 29661773

7

Clinical Scenarios Emerging from Combined Immunophenotypic, Molecular and Morphologic Analysis of Pancreatic Cancer: The Good, the Bad and the Ugly Scenario.

Karamitopoulou E, Gloor B. Karamitopoulou E, et al. Cancers (Basel). 2019 Jul 10;11(7):968. doi: 10.3390/cancers11070968. Cancers (Basel). 2019. PMID: 31295960 Free PMC article. Review.

8

Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.

Sadozai H, Acharjee A, Eppenberger-Castori S, Gloor B, Gruber T, Schenk M, Karamitopoulou E. Sadozai H, et al. Among authors: karamitopoulou e. Front Immunol. 2021 Feb 19;12:643529. doi: 10.3389/fimmu.2021.643529. eCollection 2021. Front Immunol. 2021. PMID: 33679807 Free PMC article. Clinical Trial.

9

Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity.

Sadozai H, Acharjee A, Gruber T, Gloor B, Karamitopoulou E. Sadozai H, et al. Among authors: karamitopoulou e. Cancers (Basel). 2021 Mar 4;13(5):1090. doi: 10.3390/cancers13051090. Cancers (Basel). 2021. PMID: 33806316 Free PMC article.

10

PD-1/PD-L1-Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/Predictive Subgroups.

Karamitopoulou E, Andreou A, Pahud de Mortanges A, Tinguely M, Gloor B, Perren A. Karamitopoulou E, et al. Cancer Immunol Res. 2021 Dec;9(12):1439-1450. doi: 10.1158/2326-6066.CIR-21-0144. Epub 2021 Sep 15. Cancer Immunol Res. 2021. PMID: 34526323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page